Metronidazole

Metronidazole (INN) (Flagyl, and others) is a nitroimidazole antibiotic medication used particularly for anaerobic bacteria and protozoa. Metronidazole is an antibiotic, amebicide, and antiprotozoal. It is the drug of choice for first episodes of mild-to-moderate Clostridium difficile infection. It is marketed in the U.S.A. by Pfizer and globally by Sanofi under the trade name Flagyl, and is also sold under other brand names. Metronidazole was developed in 1960.

DEA Class 3 meaning a moderate to low potential for physical and psychological dependence.

Estimated Total Cost: $29.32 for an average of 14 days supply